Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Cerebral deposition of the beta-amyloid peptide (A beta) is an invariant feature of Alzheimer's disease. Since the original isolation and characterization of A beta (ref. 1) and the subsequent cloning of its precursor protein, no direct evidence for the actual production of discrete A beta has been reported. Here we investigate whether A beta is present in human biological fluids using antibodies specific for an epitope within A beta that spans the site of normal constitutive cleavage. These antibodies were used to construct a sandwich-type enzyme-linked immunosorbent assay that detects A beta in cerebrospinal fluid, plasma and conditioned medium of human mixed-brain cells grown in vitro (see also ref. 14). By affinity chromatography, we have purified and sequenced A beta and a novel A beta fragment from human cerebrospinal fluid and conditioned medium of human mixed-brain cell cultures. These findings demonstrate that A beta is produced and released both in vivo and in vitro. These observations offer new opportunities for developing diagnostic tests for Alzheimer's disease and therapeutic strategies aimed at reducing the cerebral deposition of A beta.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies that shed light on the physiological role of Aβ in non-diseased brains show that Aβ plays a role in synaptic transmission and is involved in learning and memory formation [18–22].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [18]
In the citing paper
“Recently, we and others have shown that normal processing of the large amyloid f3 protein precursor ({3-APP) secretes 4-kDa A(3 that is readily detected in human cerebrospinal fluid and in medium conditioned by cultured cells (3)(4)(5)(6).”
From Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain (1995) · cites this paper as [3]
In the citing paper
“The demonstration that A-related peptides with the same N terminals as the CTFs documented here are present in conditioned medium of cultured cells (Seubert et al., 1992;Naslund et al., 1994;Simons et al., 1996;Wang et al., 1996;Xu et al., 1998)”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Seubert et al., 1992
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Self-citationCleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
Self-citationMutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
Self-citationChartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J., Farlow, M., Ghetti, B., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,127
Tanzi, R. E., McClatchey, A. I., Lamperti, E. D., Villa-Komaroff, L., Gusella, J. F., & Neve, R. L. (1988) · Nature · doi:10.1038/331528a0 · Cited by 1,096
Cited by
Items 1,201–1,300 of 1,726
Węgiel, J., Chauhan, A., Wı́sniewski, H. M., Nowakowski, J., Wang, K.-C., & LeVine, H. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12739-7 · Cited by 16
Bateman, D. A., & Chakrabartty, A. (2004) · Biopolymers · doi:10.1002/bip.10561 · Cited by 17
The Role of α-sheet in Amyloid Oligomer Aggregation and Toxicity.
Bi, T., & Daggett, V. (2018) · PubMed Central · Cited by 25
Molecular pathology of Alzheimer's disease
MULLAN, M. J. (1993) · International Review of Psychiatry · doi:10.3109/09540269309037798 · Cited by 16
Martá-Ariza, M., Leitner, D. F., Kanshin, E., Suazo, J., Giusti Pedrosa, A., Thierry, M., Lee, E. B., Devinsky, O., Drummond, E., Fortea, J., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02844-z · Cited by 15
Road to Alzheimer’s Disease: The Pathomechanism Underlying
Anand, R., Kaushal, A., Wani, W. Y., & Gill, K. D. (2011) · Pathobiology · doi:10.1159/000332218 · Cited by 24
Therapeutic Potential of Vaccines for Alzheimer‘s Disease
Shah, S., & Federoff, H. J. (2011) · Immunotherapy · doi:10.2217/imt.10.94 · Cited by 16
Xue, Y., Lee, S., Wang, Y., & Ha, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.219659 · Cited by 18
Misiti, F., Carelli‐Alinovi, C., Sampaolese, B., & Giardina, B. (2012) · Cell Biochemistry and Function · doi:10.1002/cbf.2822 · Cited by 15
Exploring the Potential of Neuroproteomics in Alzheimer's Disease
Uddin, M. S., Kabir, M. T., Jakaria, M., Sobarzo‐Sánchez, E., Barreto, G. E., Perveen, A., Hafeez, A., Bin-Jumah, M. N., Abdel‐Daim, M. M., & Ashraf, G. M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200603112030 · Cited by 17
Zimbone, S., Giuffrida, M. L., Sabatino, G., Natale, G. D., Tosto, R., Consoli, G. M. L., Milardi, D., Pappalardo, G., & Sciacca, M. F. M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00720 · Cited by 16
Fibrillar amyloid β-protein forms a membrane-like hydrophobic domain
Chauhan, V. P. S., Chauhan, A., & Węgiel, J. (2001) · Neuroreport · doi:10.1097/00001756-200103050-00031 · Cited by 17
Hwang, C. J., Park, M. H., Choi, M. K., Choi, J. S., Oh, K. W., Hwang, D. Y., Han, S., & Hong, J. T. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.11.013 · Cited by 19
“Ab protein is generated by proteolytic processing from its precursor, the b-amyloid precursor protein (APP) in a physiologically normal pathway (Busciglio et al., 1993; Haass et al., 1993; Haass et al., 1992; Haass and Selkoe, 1993; Seubert et al., 1992; Shoji et al., 1992).”
BackgroundLin, Y., Komatsu, H., Ma, J., Axelsen, P. H., & Fakhraai, Z. (2016) · RSC Advances · doi:10.1039/c6ra24031c · Cited by 15
Younkin, S. G. (1998) · Springer eBooks · doi:10.1007/978-3-642-72103-8_4 · Cited by 17
Aβ Upregulates and Colocalizes with LGI3 in Cultured Rat Astrocytes
Kimura, N., Ishii, Y., Suzaki, S., Negishi, T., Kyuwa, S., & Yoshikawa, Y. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9127-8 · Cited by 18
“Aβ40, the Aβ species thought to be the primary form of Aβ found in normal brain (Haas et al., 1992; Seubert et al., 1992; Shoji et al., 1992; Busciglio et al., 1993; VigoPelfrey et al., 1993), is less toxic than Aβ42 (Burdick et al., 1992; Jarrett et al., 1993; Suzuki et al., 1994; Younkin, 1994).”
BackgroundIs the LDL Receptor Involved in Cortical Amyloid Protein Clearance?
Abdulkarim, Y., & Hameed, Z. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9084-0 · Cited by 15
“Abeta is a normal physiological product of APP processing [9–11] and a soluble component of the plasma and the cerebrospinal fluid [12].”
Thompson, A., Grueninger‐Leitch, F., Huber, G., & Malherbe, P. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00091-0 · Cited by 15
Synthesis and Secretion of Active α1-Antichymotrypsin by Murine Primary Astrocytes
Kanemaru, K., Meckelein, B., Marshall, D. C. L., Sipe, J. D., & Abraham, C. R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00111-x · Cited by 18
Expression of β-amyloid precursor protein in the developing human spinal cord
Arai, H., Higuchi, S., Matsushita, S., Yuzuriha, T., Trojanowski, J. Q., & Lee, V. M. ‐. (1994) · Brain Research · doi:10.1016/0006-8993(94)90914-8 · Cited by 15
Chauhan, A., Pirttilä, T., Mehta, P. D., Chauhan, V. P. S., & Wísniewski, H. M. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00123-2 · Cited by 15
Buckland, P. R., Tidmarsh, S. F., Spurlock, G., Kaiser, F., Yates, M., O'Mahony, G., & McGuffin, P. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90095-7 · Cited by 15
Katzman, R. (1995) · Comprehensive physiology · doi:10.1002/cphy.cp110112 · Cited by 17
The reduction of astrocytic tau prevents amyloid-β-induced synaptotoxicity
Cisternas, P., Taylor, X., Martínez, P., Maldonado, O., Jury, N., & Lasagna‐Reeves, C. A. (2022) · Brain Communications · doi:10.1093/braincomms/fcac235 · Cited by 15
Impellizzeri, D., Tomasello, M., Cordaro, M., D’Amico, R., Fusco, R., Abdelhameed, A. S., Wenzel, U., Siracusa, R., Calabrese, V., Cuzzocrea, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086938 · Cited by 16
“Furthermore, the Aβ peptide would seem to have a crucial role in biological fluids and in the cells they contain [4].”
BackgroundEffects of Amyloid β-Peptides and Gangliosides on Mouse Neural Stem Cells
Itokazu, Y., Kato‐Negishi, M., Nakatani, Y., Ariga, T., & Yu, R. K. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1108-y · Cited by 16
“Abs is produced by cultured cells during normal cellular metabolism [55, 56].”
BackgroundBusch, L., Taleb, Z. A., Tsai, Y., Nguyen, V. T. T., Lu, Q., Synatschke, C. V., Endres, K., & Bufe, B. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102642 · Cited by 14
“Indeed, several studies suggest that Aβ11-40/42 is present in the cerebrospinal fluid at similar concentrations as Aβ1-42 and is furthermore an integral part of senile plaques (54, 65, 66).”
BackgroundBiological CSF Markers of Alzheimer's Disease
Zetterberg, H., & Blennow, K. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01224-9 · Cited by 17
Copper induces the accumulation of amyloid-beta in the brain
Kim, D.-K., Song, J., Park, J., & Choi, B. (2013) · Molecular & Cellular Toxicology · doi:10.1007/s13273-013-0009-0 · Cited by 16
Li, C.-D., Xu, Q., Gu, R., Qu, J. T., & Wei, D. (2017) · Physical Chemistry Chemical Physics · doi:10.1039/c6cp07873g · Cited by 14
Adsorption of Amyloid β (1-40) Peptide at Liquid Interfaces
Brezesinski, G., Maltseva, E., & Möhwald, H. (2006) · Zeitschrift für Physikalische Chemie · doi:10.1524/zpch.2007.221.1.95 · Cited by 14
Kar, S. (2002) · Drug Development Research · doi:10.1002/ddr.10080 · Cited by 17
“NEURON INTERACTONS Ab-related peptides are produced constitutively by brain cells and are found in pM–nM range in the CSF of normal individuals [Haass et al., 1992; Seubert et al., 1992; Shoji et al., 1992; Selkoe, 2001].”
pH-Dependent Conformational Ensemble and Polymorphism of Amyloid-β Core Fragment
Xu, W., Zhang, C., Morozova‐Roche, L. A., Zhang, J. Z. H., & Mu, Y. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp404034x · Cited by 13
Pérez-Garmendia, R., Ibarra-Bracamontes, V., Vasilevko, V., Luna‐Muñoz, J., Mena, R., Govezensky, T., Acero, G., Manoutcharian, K., Cribbs, D. H., & Gevorkian, G. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.020 · Cited by 15
“The main Aβ variants detected in thehumanbrain areAβ1-40 andAβ1-42, however a significant proportion of AD brain Aβ consists also of N-terminal truncated/modified species (Guntert et al., 2006;Mori et al., 1992; Saido et al., 1995; Seubert et al., 1992; Tekirian et al., 1998;Wirths et al., 2010).”
Evidence for D-Aspartyl-β-Amyloid Secretase Activity in Human Brain
Lee, J. M., Petrucelli, L., Fisher, G., Ramdath, S., Castillo, J., Fiore, M. M. D., & D’Aniello, A. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.2.125 · Cited by 15
“It has been observed that Ab is found mostly in the soluble form in the brain, cerebrospinal fluid (CSF), and in other tissues of healthy individuals (14).”
BackgroundBeta-amyloid imaging in dementia
Chun, K. A. (2018) · Journal of Yeungnam Medical Science · doi:10.12701/yujm.2018.35.1.1 · Cited by 16
“2), and Aβ is detected not only in amyloid plaques but also in cortical arteries, CSF, plasma, and neuronal culture [7].”
BackgroundMolecular biology and genetics of Alzheimer's disease
Jiménez‐Escrig, A., Blanco-Jerez, C., & Orensanz, L. (1995) · European Journal of Neurology · doi:10.1111/j.1468-1331.1995.tb00157.x · Cited by 14
Olesen, O. F., Mikkelsen, J. D., Gerdes, C., & Jensen, P. H. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00196-9 · Cited by 14
??-Amyloid Disrupting Drugs: Potential in the Treatment of Alzheimer??s Disease
Soto, C. A. (1999) · CNS Drugs · doi:10.2165/00023210-199912050-00002 · Cited by 17
Biological Markers for Alzheimer's Disease
Tapiola, T. (2001) · Cited by 28
Lee, J., Shin, H.-J., Chang, C., & Paik, S. R. (1998) · Neurochemical Research · doi:10.1023/a:1020711025418 · Cited by 15
Involvement of amyloid as a central step in the development of Alzheimer's disease
Robakis, N. K. R. K., & Pangalos, M. N. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90189-9 · Cited by 14
PROCTER, A. W., Francis, P. T., Holmes, C., Webster, M.-T., Qume, M., Stratmann, G. C., Doshi, R. N., Mann, D. M. A., Harrison, P. J., Pearson, R. C. A., et al. (1994) · Acta Neuropathologica · doi:10.1007/bf00296491 · Cited by 14
Targeting APP metabolism for the treatment of Alzheimer's disease
Sambamurti, K., Hardy, J., Refolo, L. M., & Lahiri, D. K. (2002) · Drug Development Research · doi:10.1002/ddr.10077 · Cited by 16
Heterogeneity in Alzheimer's Disease
Hardy, J., & Duff, K. (1993) · Annals of Medicine · doi:10.3109/07853899309147308 · Cited by 14
Wang, Z., Jin, M., Hong, W., Liu, W., Reczek, D., Lagomarsino, V. N., Hu, Y., Weeden, T., Frosch, M. P., Young‐Pearse, T. L., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01511-2 · Cited by 15
Self-citationReed, A. L., Mitchell, W., Alexandrescu, A. T., & Alder, N. N. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1263420 · Cited by 13
Cell Surface Binding and Internalization of Aβ Modulated by Degree of Aggregation
Bateman, D. A., & Chakrabartty, A. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/962352 · Cited by 14
“D. A. Bateman was supported by a scholarship from NSERC and a SCACE graduate fellowship.”
Aβ-40 Y10F Increases βfibrils Formation but Attenuates the Neurotoxicity of Amyloid-β Peptide
Dai, X., Chang, P., Liu, W., Xu, K., Sun, Y., Zhu, S., & Jiang, Z.-F. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13055324 · Cited by 14
“ubiquitous transmembrane protein, termed the amyloid precursor protein (APP), by the action of β- and -secretases [2,3].”
BackgroundVascular dysfunction-associated with Alzheimer’s disease
Carelli‐Alinovi, C., Dinarelli, S., Girasole, M., & Misiti, F. (2016) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-168047 · Cited by 13
Chauhan, A., Pirttilä, T., Chauhan, V. P. S., Mehta, P. D., & Wísniewski, H. M. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00221-9 · Cited by 13
The role of beta-amyloid in Alzheimer's disease
Sinha, S. (2002) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00022-6 · Cited by 14
“The recognition that the Ab peptides are actually normal metabolites of APP came about as the consequence of the discovery that primary human neuronal cells release Ab peptides, Ab1-40, as well as Ab11-40, in their culture medium [6], and that tissue culture cell lines, such as HEK293 that are transfected with APP als…”
BackgroundSelf-citationHanley, M. R., & Selkoe, D. J. (1993) · Nature · doi:10.1038/362014a0 · Cited by 13
Self-citationAlzheimer's disease — from cause to cure?
Vines, G. (1993) · Trends in biotechnology · doi:10.1016/0167-7799(93)90122-p · Cited by 13
Soluble Oligomers of the Amyloid β-Protein: Impair Synaptic Plasticity and Behavior
Selkoe, D. J. (2008) · Springer eBooks · doi:10.1007/978-3-540-76330-7_8 · Cited by 18
Self-citationTsuzuki, K., Fukatsu, R., Takamaru, Y., Yoshida, T., Mafune, N., Kobayashi, K., Fujii, N., & Takahata, N. (1995) · Brain Research · doi:10.1016/0006-8993(95)00917-f · Cited by 15
Smith, C., Stanyer, L., & Betteridge, D. J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.094 · Cited by 13
Arai, T., Akiyama, H., Ikeda, K., Kondo, H., & Mori, H. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01366-3 · Cited by 13
Model systems to study the β-amyloid protein of Alzheimer’s disease
Sandhu, F. A. (1994) · AGE · doi:10.1007/bf02435044 · Cited by 13
Yoshikawa, K. (1993) · Nature · doi:10.1038/361122b0 · Cited by 13
Hartmann, H., Eckert, A., Crews, F. T., & Muller, W. E. (1996) · Amyloid · doi:10.3109/13506129609014370 · Cited by 14
KAPLITT, M., GOURAS, G. K., MAKIMURA, H., JOVANOVIC, J., SWEENEY, D., GREENGARD, P., RELKIN, N. R., & GANDY, S. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32597.x · Cited by 12
Liu, L. L., Shen, X., Gu, H., Zhao, G., Du, Y., & Zheng, W. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00432-5 · Cited by 12
“In AD brains, Ab is found in the cerebrospinal fluid (CSF) circulating in brain ventricles, in the interstitial fluid (ISF) bathing neurons and glial cells and in cerebral vasculature [42, 49, 51, 61].”
BackgroundChia, S., Cataldi, R., Ruggeri, F. S., Limbocker, R., Morales, I. C., Pisani, K., Possenti, A., Linse, S. S., Knowles, T. P. J., Habchi, J., et al. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00718 · Cited by 12
The P’s and Q’s of cellular PrP-Aβ interactions
Westaway, D. A., & Jhamandas, J. H. (2012) · Prion · doi:10.4161/pri.20675 · Cited by 15
Paul, A., Kumar, S., Kalita, S., Kalita, S., Sarkar, D., Bhunia, A., Bandyopadhyay, A., Mondal, A. C., & Mandal, B. (2020) · Chemical Science · doi:10.1039/d0sc04379f · Cited by 12
Recent advances in pre-clinical diagnosis of Alzheimer’s disease
Zhou, J., Benoit, M., & Sharoar, M. G. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00733-4 · Cited by 15
“Aβ is spontaneously generated as a soluble protein during normal cellular metabolic activity and is secreted into various biological fluids including cerebrospinal fluid (CSF), which is in direct contact with the brain parenchyma (Seubert et al. 1992; Andreasen et al. 1999; Blennow et al. 2010).”
BackgroundRed Blood Cells’ Thermodynamic Behavior in Neurodegenerative Pathologies and Aging
Todinova, S., Krumova, S., Bogdanova, D., Danailova, A., Zlatareva, E., Kalaydzhiev, N., Langari, A., Milanov, I., & Taneva, S. (2021) · Biomolecules · doi:10.3390/biom11101500 · Cited by 12
“Conceivably, the shifts we observed in the unfolding temperatures of those major RBCs proteins might result from their significantly different binding state considering the well-known presence of low levels of misfolded peptides in RBCs as well as in blood plasma [59,60], which might directly interact with RBC and pla…”
BackgroundTian, Y., Liu, J., Yang, F., Lian, C., Zhang, H., Viles, J. H., & Li, Z. (2022) · FEBS Journal · doi:10.1111/febs.16550 · Cited by 12
Noormägi, A., Golubeva, T., Berntsson, E., Wärmländer, S. K. T. S., Tõugu, V., & Palumaa, P. (2023) · ACS Omega · doi:10.1021/acsomega.3c04649 · Cited by 12
Alzheimer's disease and melatonin
Matsubara, E., Shoji, M., Murakami, T., Kawarabayashi, T., & Abe, K. (2003) · International Congress Series · doi:10.1016/s0531-5131(03)00019-0 · Cited by 14
Ross, J. A., Reyes, B. A. S., THOMAS, S. A., & Bockstaele, E. J. V. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1489-9 · Cited by 12
“Over a decade has passed since the recognition of Ab as an endogenous neuropeptide undergoes physiological metabolism in the central nervous system (Haass et al. 1992; Seubert et al. 1992; Shoji et al. 1992); and yet, its physiological function is not well understood.”
BackgroundWireless USB-like electrochemical platform for individual electrochemical sensing in microdroplets
Zhou, Z., Wang, J., Li, G., Chen, Y., Xu, T., & Zhang, X. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.339526 · Cited by 12
Imaging amyloid β peptide oligomeric particles in solution
Dong, J., Apkarian, R. P., & Lynn, D. G. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.05.052 · Cited by 13
Carelli‐Alinovi, C., Giardina, B., & Misiti, F. (2015) · Cell Biochemistry and Function · doi:10.1002/cbf.3103 · Cited by 12
“In addition to Abeta deposition in neurons, Abeta is generated at high levels in platelets(4) and it is present at nanomolar concentration in blood.(5) Red blood cells (RBCs) are also exposed to Abeta on the luminal surfaces of cerebral microvessels(6) and have been reported to interact with RBC in peripheral blood.”
BackgroundVillemagne, V. L., Ng, S., Cappai, R., Barnham, K. J., Fodero‐Tavoletti, M. T., Rowe, C. C., & Masters, C. L. (2006) · The Neuroradiology Journal · doi:10.1177/197140090601900406 · Cited by 12
Shea, T. B., & Ortiz, D. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5408 · Cited by 12
Demonstration of amyloid β-protein secretion in a mouse neuronal cell line
Araki, W., Kunishita, T., Takahashi, K., Ikeda, S., & Tabira, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)91043-x · Cited by 12
Wallace, W., & Haroutunian, V. H. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90136-e · Cited by 12
Peripheral Markers and Diagnostic Criteria in Alzheimer's Disease: Critical Evaluations
de Lustig, E. S., Kohan, S., Famulari, A. L., Domínguez, R. O., & Serra, J. A. (1994) · Reviews in the Neurosciences · doi:10.1515/revneuro.1994.5.3.213 · Cited by 14
Alzheimer’s disease and transgenic mice
Czech, C., Masters, C. L., & Beyreuther, K. T. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9350-1_17 · Cited by 13
Expression and processing of pathologic proteins in alzheimer's disease
Anderton, B. H. (1993) · Hippocampus · doi:10.1002/hipo.1993.4500030726 · Cited by 12
“However, it has now been shown that a 4 kd P-amyloid peptide (residues 1-40) and a 3 kd (residues 11-46, numbering corresponding to f3-amyloid residue numbers within APP) fragment are secreted by cells in culture, and these fragments are present in plasma and cerebral spinal fluid (Haass et al., 1992b; Seubert et al.,…”
BackgroundDavies, T. A., Long, H. J., Rathbun, W., Sgro, K., Tibbles, H. E., Smith, S. J., Seetoo, K. F., McMenamin, M. E., Johnson, R. J., Wells, J. M., et al. (1996) · Amyloid · doi:10.3109/13506129609014350 · Cited by 12
Bourbonnière, M., Shekarabi, M., & Nalbantoglu, J. N. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68030909.x · Cited by 13
Characterization of a novel processing pathway for Alzheimer's amyloid β precursor protein
Ghiso, J. A., Gardella, J. E., Liem, L.-K., Gorevic, P. D., & Frangione, B. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90642-4 · Cited by 12
Yin, L., Li, W., Chu, Y., & Li, L. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.013 · Cited by 12
Ganglioside-Dependent Neural Stem Cell Proliferation in Alzheimer’s Disease Model Mice
Koon, N. A., Itokazu, Y., & Yu, R. K. (2015) · ASN NEURO · doi:10.1177/1759091415618916 · Cited by 11
“Abs are produced by cultured cells as part of the normal cellular metabolism (Haass et al., 1992; Seubert et al., 1992).”
BackgroundActor-Engel, H. S., Schwartz, S. L., Crosby, K. C., Sinnen, B. L., Prikhodko, O., Ramsay, H. J., Bourne, J. N., Winborn, C. S., Lucas, A., Smith, K. R., et al. (2021) · eNeuro · doi:10.1523/eneuro.0416-21.2021 · Cited by 12
“November/December 2021, 8(6) ENEURO.0416-21.2021 1–15 plaques associated with AD (Seubert et al., 1992; Shoji et al., 1992; Lambert et al., 1998; Gong et al., 2003; Lesné et al., 2006).”
InfluentialEffect of isomerization of aspartate-7 on the binding of copper (II) ion by the β-amyloid peptide
Tsvetkov, F. O., Makarov, A. А., Archakov, A. I., & Kozin, S. A. (2009) · BIOPHYSICS · doi:10.1134/s0006350909020018 · Cited by 12
Paul, A., Kumar, S., Kalita, S., Ghosh, A. K., Mondal, A. C., & Mandal, B. (2017) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-017-9602-8 · Cited by 12
“Human cerebrospinal fluid (h-CSF) is in direct contact with the extracellular space of the neuronal cells (Seubert et al. 1992; Andreasen et al. 1999; Muthuraj et al. 2015).”
Subash, P., & Rao, K. S. (2021) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2021.101285 · Cited by 12
BACE/APPV717F Double-Transgenic Mice Develop Cerebral Amyloidosis and Inflammation
Ozmen, L., Woolley, M. L., Albientz, A., Miss, M.-T., Nelboeck, P., Malherbe, P., Czech, C., Grüninger-Leitch, F., Brockhaus, M., Ballard, T. M., et al. (2005) · Neurodegenerative Diseases · doi:10.1159/000092314 · Cited by 11
“The 12-kDa fragment may then undergo γ-secretase cleavage within the hydrophobic transmembrane domain to release predominantly the 40-, 42- and 38-residue Aβ peptides [”
BackgroundProtein Folding, Nucleation Phenomena and Delayed Neurodegeneration in Alzheimer's Disease
Fox, N. C., Harvey, R. J., & Rossor, M. N. (1996) · Reviews in the Neurosciences · doi:10.1515/revneuro.1996.7.1.21 · Cited by 13
Schneider, M., Walta, S., Cadek, C., Richtering, W. H., & Willbold, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-02410-y · Cited by 11
“4) to the linear extrapolation model (equation (3)).”
InfluentialLi, Q., Cappai, R., Evin, G. M., Tanner, J. E., Gray, C. W., Beyreuther, K. T., & Masters, C. L. (1998) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331759801300504 · Cited by 11
Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease
Reitz, C., van Rooij, F. J. A., de Maat, M. P. M., den Heijer, T., Albert Hofman, D., Witteman, J. C. M., & Breteler, M. M. B. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.001 · Cited by 11
Effect of β-amyloid peptide on behavior and synaptic plasticity in terrestrial snail
Samarova, E. I., Bravarenko, N. I., Korshunova, T., Gulyaeva, N. V., Palotás, A., & Balaban, P. M. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.05.023 · Cited by 11
Iwata, R., Kitagawa, K., Zhang, N., Wu, B., & Inagaki, C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.05.103 · Cited by 11
Zambrzycka, A., Strosznajder, R. P., & Strosznajder, J. B. (2000) · Neurochemical Research · doi:10.1023/a:1007511217525 · Cited by 14
“Aβ (1-40) enhanced the level of malondialdehyde indicating an activation of free radical stimulated membrane lipid peroxidation that may be involved in alteration of phospholipase(s) activity.”
BackgroundInfluentialNeuronal membrane conductance activated by amyloid β peptide: importance of peptide conformation
Li, W., Czilli, D. L., & Simmons, L. K. (1995) · Brain Research · doi:10.1016/0006-8993(95)00264-q · Cited by 12
Metadata
- Authors
- Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., & Schenk, D.
- Affiliations
- Austrian Academy of Sciences (AT)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6393
- Pages
- 325-327
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2086278983
- Cited by
- 1,731
- References
- 28
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 32 · 2023: 19 · 2022: 22 · 2021: 31 · 2020: 28 · 2019: 25 · 2018: 35 · 2017: 39 · 2016: 31 · 2015: 48 · 2014: 46 · 2013: 39 · 2012: 50
- FWCI
- 72.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, cerebrospinal fluid, plasma, conditioned medium, sandwich ELISA, affinity chromatography, epitope-specific antibodies, amyloid deposition, diagnostic biomarkers
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Antibodies, Monoclonal, Brain, Cells, Cultured, Cross Reactions, Enzyme-Linked Immunosorbent Assay, Humans, Molecular Sequence Data, Peptide Fragments, Radioimmunoassay, Solubility, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.